XML 192 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Supplemental Balance Sheet Information - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
[1]
Inventory [Line Items]          
Inventory $ 710,975   $ 710,975   $ 698,548
Depreciation expense, net of amounts capitalized into inventory 11,800 $ 9,700 24,300 $ 20,000  
Vosoritide          
Inventory [Line Items]          
Inventory $ 9,600   $ 9,600    
[1] (1)December 31, 2020 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 26, 2021.